Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 39 Docetaxel 30 Tamoxifen 29 Paclitaxel 27 Doxorubicin 26 Trastuzumab 20 Radiotherapy 18 Epirubicin 16 Letrozole 13 exemestane 11 Fluorouracil 11 Anastrozole 11 Capecitabine 10 Bevacizumab 10 Immunohistochemistry 9 Filgrastim 9 Fulvestrant 8 Methotrexate 7 Gene Expression Profiling 7 palbociclib 6 Zoledronic Acid 6 Microarray Analysis 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 Vinorelbine 5 Triptorelin Pamoate 5 Carboplatin 5 Absorptiometry, Photon 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × Toremifene × Clear all

NCT00002529 2013-04-04

12-93

ETOP IBCSG Partners Foundation

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡